Published in Eur J Cancer on February 01, 1998
Recombinant human erythropoietin attenuates weight loss in a murine cancer cachexia model. J Cancer Res Clin Oncol (2004) 0.80
The efficacy of recombinant human erythropoietin in treatment chemotherapy induced anemia in children diagnosed with a solid cancer. Iran J Ped Hematol Oncol (2014) 0.75
SIOP Working Committee on Psychosocial issues in pediatric oncology: guidelines for care of long-term survivors. Med Pediatr Oncol (1996) 1.42
Polymorphic DNA haplotypes at the phenylalanine hydroxylase (PAH) locus in European families with phenylketonuria (PKU). Am J Hum Genet (1989) 1.41
Evaluation of serious adverse events in patients treated with protocols including methotrexate infusions. Pediatr Hematol Oncol (1994) 1.41
Heterogeneous spectrum of mutations in the Fanconi anaemia group A gene. Eur J Hum Genet (1999) 1.36
Familial occurrence of congenital malformations and ring chromosome (46,XX,Cr). J Med Genet (1970) 1.19
The adverse effect of prolonged prednisolone pretreatment in children with acute lymphoblastic leukemia. Cancer (1985) 1.18
Conduct of phase I trials in children with cancer. J Clin Oncol (1998) 1.16
Human recombinant granulocyte-macrophage colony-stimulating factor in pediatric oncology practice. Pediatr Hematol Oncol (1994) 1.08
Childhood leukaemia in Europe after Chernobyl: 5 year follow-up. Br J Cancer (1996) 1.04
Morphological diagnosis in childhood leukaemia. Br J Haematol (1978) 1.01
Christmas disease in one of a pair of monozygotic twin girls, possibly the effect of lyonization. J Med Genet (1972) 0.96
A comparative study on the pharmacokinetics of methotrexate in a dose range of 0.5 g to 33.6 g/m2 in children with acute lymphoblastic leukemia. Cancer (1987) 0.94
[Current methods for study of human chromosomes]. Orv Hetil (1965) 0.94
The pathological response and fate in the lung and pleura of chrysotile in combination with fine particles compared to amosite asbestos following short-term inhalation exposure: interim results. Inhal Toxicol (2010) 0.92
Psychosocial problems in families of a child with cancer. Med Pediatr Oncol (1985) 0.91
Guidelines for a therapeutic alliance between families and staff: a report of the SIOP Working Committee on Psychosocial Issues in Pediatric Oncology. Med Pediatr Oncol (1998) 0.90
Molecular genetics of PKU in eastern Europe: a nonsense mutation associated with haplotype 4 of the phenylalanine hydroxylase gene. Somat Cell Mol Genet (1990) 0.89
Hemihypertrophy: 10 years follow-up and chromosomal study. Acta Paediatr Acad Sci Hung (1965) 0.88
Development of a (32)P-postlabeling method for the detection of 1,N(2)-propanodeoxyguanosine adducts of trans-4-hydroxy-2-nonenal in vivo. Chem Res Toxicol (2000) 0.86
Quantification of the pathological response and fate in the lung and pleura of chrysotile in combination with fine particles compared to amosite-asbestos following short-term inhalation exposure. Inhal Toxicol (2011) 0.85
Coping with cadmium exposure in various ways: the two helicid snails Helix pomatia and Cantareus aspersus share the metal transcription factor-2, but differ in promoter organization and transcription of their Cd-metallothionein genes. J Exp Zool A Ecol Genet Physiol (2009) 0.83
Psychological late effects of leukemia in children and their prevention. Med Pediatr Oncol (1981) 0.83
Thyroid autoantibodies and satellite associations in Down's syndrome. Hum Hered (1970) 0.83
Cancer risk assessment for crotonaldehyde and 2-hexenal: an approach. IARC Sci Publ (1999) 0.81
Leukaemia in children with Down's syndrome. Oncology (1983) 0.81
Chromosomal peculiarities and "in vitro" examinations in Fanconi's anaemia. Humangenetik (1969) 0.80
Phytohaemagglutinin-induced leukocyte migration inhibition and phytohaemagglutinin skin test for screening the cell-mediated immune response in children. Allergy (1980) 0.80
Administration of Ethyol (amifostine) to a child with medulloblastoma to ameliorate hematological toxicity of high dose carboplatin. Anticancer Drugs (1996) 0.79
Lymphoblastic transformation, chromosome pattern and delayed-type skin reaction in ataxia telangiectasia. Acta Paediatr Scand (1971) 0.79
Cell-mediated immune response in patients with Down's syndrome. Acta Paediatr Acad Sci Hung (1974) 0.79
[Pituitary function and growth in children under treatment for leukemia (author's transl)]. Monatsschr Kinderheilkd (1980) 0.79
No clastogenic activity of a senna extract in the mouse micronucleus assay. Mutat Res (1999) 0.79
[Neurologic complications of childhood malignancies]. Orv Hetil (1994) 0.79
Immunological and virological investigations in Down's syndrome. Eur J Pediatr (1982) 0.79
Consumer evaluation of the quality of hospital services from an economics of information perspective. J Health Care Mark (1990) 0.78
L-asparaginase therapy and its complications in acute lymphoid leukaemia and generalized lymphosarcoma. Haematologia (Budap) (1976) 0.78
[Prognostic significance of systemic clearance of methotrexate in acute lymphoid leukemia in childhood]. Orv Hetil (1986) 0.77
Methotrexate administered by 6-h and 24-h infusion: a pharmacokinetic comparison. Cancer Chemother Pharmacol (1988) 0.76
The association of HLA-DR5 antigen with longer survival in childhood leukaemia. Br J Haematol (1981) 0.76
Safety of dexrazoxane in children with all undergoing anthracycline therapy: preliminary results of a prospective pilot study. Pediatr Hematol Oncol (1997) 0.76
Paraneoplastic syndrome in childhood. Acta Paediatr Acad Sci Hung (1977) 0.75
Acute myeloid leukemia in childhood: 12 years experience of treatment in Hungary. Haematologia (Budap) (1985) 0.75
Causes of low birthweight in Hungary. Acta Paediatr Hung (1984) 0.75
Lymphocyte markers in childhood ALL: the lack of correlation with prognosis. Acta Paediatr Acad Sci Hung (1982) 0.75
[Use of computer methods in the therapeutic follow-up of leukemia patients]. Orv Hetil (1981) 0.75
[Further comments on visiting the hospitalized child]. Orv Hetil (1980) 0.75
[Infant mortality and infant care in Hungary]. Orv Hetil (1981) 0.75
The treatment of childhood leukaemia in Hungary. On behalf of the Hungarian Working Party on Childhood Leukaemia. Haematologia (Budap) (1982) 0.75
[Relationship between HLA-DR5 antigen and survival in acute childhood leukemia]. Orv Hetil (1981) 0.75
[Congenital developmental anomalies in the offspring of epileptic mothers]. Orv Hetil (1985) 0.75
Infant leukemia in Hungary. Med Pediatr Oncol (1982) 0.75
[Effect of previous prednisolone therapy on the survival of children with acute lymphoid leukemia]. Orv Hetil (1984) 0.75
Recent results in cancer research related to non-solid tumors in children. Osterr Z Onkol (1977) 0.75
Naloxone antagonises effect of alpha-gliadin on leucocyte migration in patients with coeliac disease. Lancet (1985) 0.75
The prognostic significance of bone and joint manifestations in childhood leukemia. J Rheumatol (1985) 0.75
Prognostic importance of systemic clearance of methotrexate in childhood acute lymphoblastic leukemia. Cancer Chemother Pharmacol (1987) 0.75
[Management of infantile Hodgkin's disease with combined chemotherapy]. Orv Hetil (1984) 0.75
Chromosome mutations and chromosome stability in children treated with different regimes of immunosuppressive drugs. Hum Hered (1979) 0.75
[Methotrexate levels in the blood and cerebrospinal fluid in children with acute lymphoid leukemia treated with medium doses of methotrexate]. Orv Hetil (1984) 0.75
Cytogenetic studies on peripheral blood cultures of neonates treated in an intensive unit. Acta Paediatr Hung (1986) 0.75
Aclacinomycin-A in the induction treatment of childhood acute myelogenous leukemia. Haematol Blood Transfus (1987) 0.75
[Dr. Odön Kerpel-Fronius (1906-1984)]. Orv Hetil (1984) 0.75
Late effects of therapy in children previously treated for leukaemia or malignant tumour. Acta Paediatr Hung (1983) 0.75
Aclacinomycin-A in the induction treatment of childhood AML. Onkologie (1986) 0.75
The investigation of late cytogenetic effects in children with acute leukaemia in long remission and off all chemotherapy. Hum Genet (1981) 0.75
Lymphocyte subpopulations in peripheral blood of small-for-gestational age and appropriate-for-gestational age preterm neonates. Acta Paediatr Hung (1984) 0.75
[Late cytogenetic studies in children with leukemia in remission, after cessation of therapy]. Orv Hetil (1981) 0.75
[Iatrogenic carcinogenesis]. Orv Hetil (1978) 0.75
Childhood leukaemia: therapeutic and experimental approach. Acta Paediatr Acad Sci Hung (1981) 0.75
[Results and problems in the treatment of childhood leukaemia (author's transl)]. Monatsschr Kinderheilkd (1978) 0.75
[Iron-deficiency and replacement in infancy]. Monatsschr Kinderheilkd (1982) 0.75
[Results of the treatment of nephroblastoma (Wilms' tumor) in Hungary]. Orv Hetil (1988) 0.75
[Changes in thyroid function after treatment of malignant childhood diseases]. Orv Hetil (1988) 0.75
[Indication and results of bone marrow transplantation in childhood]. Orv Hetil (1984) 0.75
[The child and the hospital. Preventable psychological damage]. Orv Hetil (1987) 0.75
[Acute childhood leukemia]. Orv Hetil (1988) 0.75
[Deep-freezing of boar semen: a comparison of two methods]. Schweiz Arch Tierheilkd (1979) 0.75
Developmental changes in lymphocyte surface markers. Acta Paediatr Acad Sci Hung (1982) 0.75
[Sudden infant death]. Orv Hetil (1987) 0.75
[Iron deficiency and iron substitution in infancy]. Orv Hetil (1982) 0.75
[Congenital and hereditary nephropathies in children based on epidemiological research data]. Vestn Akad Med Nauk SSSR (1984) 0.75
Childhood rhabdomyosarcoma in Hungary. Neoplasma (1987) 0.75
[New aspects of the determination of blood methotrexate levels in leukemic children]. Monatsschr Kinderheilkd (1986) 0.75
[[Incidence of X-chromosome fragility in medium and severe mental retardation]. Orv Hetil (1984) 0.75
[Prognosis and therapy of acute lymphoid leukemia in childhood]. Orv Hetil (1986) 0.75
Sister chromatid exchange in childhood malignancies. Teratog Carcinog Mutagen (1983) 0.75
[Glucocorticoid receptors in acute childhood leukemia]. Orv Hetil (1980) 0.75
Prognostic factors in acute lymphoid leukaemia of childhood. I. Cytogenetic studies. Acta Paediatr Hung (1986) 0.75
[Leukemia in infancy in Hungary]. Orv Hetil (1982) 0.75
[Role of cytogenetic studies in acute non-lymphoid leukemia in children]. Orv Hetil (1985) 0.75
[Use of the recombination gene technic (gene splicing) in clinical medicine]. Orv Hetil (1985) 0.75
[Comparative study of age-related surface markers of lymphocyte subpopulations]. Orv Hetil (1981) 0.75
Cytogenetic investigations on children with acute non-lymphocytic leukemia. Blut (1988) 0.75
[Results and new trends in the treatment of childhood leukemia]. Orv Hetil (1982) 0.75
Prognostic factors in acute lymphoid leukaemia of childhood. II. Cell surface markers. Acta Paediatr Hung (1986) 0.75
Virus-specific reverse transcriptase in acute leukaemia. Acta Paediatr Acad Sci Hung (1981) 0.75
Antibody-dependent and spontaneous cell-mediated cytotoxicity in children with acute lymphoblastic leukemia. Allergol Immunopathol (Madr) (1983) 0.75
[The tradition of pediatric hospitals in Hungary. Past, present and future (are our pediatric departments sufficiently child-centered?)]. Orv Hetil (1984) 0.75